-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Evelo Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2023.
- Evelo Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 17.4M shares, a 222% increase year-over-year.
- Evelo Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 87.2M shares, a 64.7% increase from 2021.
- Evelo Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 52.9M shares, a 34% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)